Target commercial insurance or cash-pay patients
IV Delivery vs Oral Supplements - What Is the Actual Difference
Semaglutide 2.4 mg hits 12 to 15 percent mean loss by 68 to 104 weeks in STEP programs
If a clinician elects to prescribe ipamorelin in this population, the dose should not exceed 100 mcg once daily, liver transplant candidacy should be documented, and an endocrinologist should co-manage the case
Retatrutide: The Triple Agonist Thats Redrawing the Map of Obesity Medicine Updated with TRIUMPH-1 and TRANSCEND-T2D-1 Phase 3 data presented at the ADA 86th Scientific Sessions (June 2026) The Short Version Retatrutide (LY3437943, Eli Lilly) is an investigational, once-weekly subcutaneous peptide that hits three metabolic receptors at once: GIP, GLP-1, and glucagon
GLP-1 receptors exist in brain regions involved in attention and impulse control, but this does not establish clinical efficacy for ADHD